The novel oral drug Subetta exerts an antidiabetic effect in the diabetic Goto-Kakizaki rat: comparison with rosiglitazone.

Bailbé D, Philippe E, Gorbunov E, Tarasov S, Epstein O, Portha B

DOI: 10.1155/2013/763125
Published: 2013
Container: Journal of diabetes research
Publisher: Not recorded
Open access: yes

Credibility signals

serious concern Score 27/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
serious concernRetraction Watch expression of concern: 1 expression of concern notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1155/2013/763125,
  title = {The novel oral drug Subetta exerts an antidiabetic effect in the diabetic Goto-Kakizaki rat: comparison with rosiglitazone.},
  author = {Bailbé D and Philippe E and Gorbunov E and Tarasov S and Epstein O and Portha B},
  year = {2013},
  journal = {Journal of diabetes research},
  doi = {10.1155/2013/763125},
  url = {https://doi.org/10.1155/2013/763125}
}

RIS

TY  - JOUR
TI  - The novel oral drug Subetta exerts an antidiabetic effect in the diabetic Goto-Kakizaki rat: comparison with rosiglitazone.
AU  - Bailbé D
AU  - Philippe E
AU  - Gorbunov E
AU  - Tarasov S
AU  - Epstein O
AU  - Portha B
PY  - 2013
JO  - Journal of diabetes research
DO  - 10.1155/2013/763125
UR  - https://doi.org/10.1155/2013/763125
ER  -

APA

D, B., E, P., E, G., S, T., O, E., & B, P. (2013). The novel oral drug Subetta exerts an antidiabetic effect in the diabetic Goto-Kakizaki rat: comparison with rosiglitazone.. Journal of diabetes research. https://doi.org/10.1155/2013/763125

Source records

pubmed · retrieved 2026-09-25T04:12:18.471Z